Drugs / RaproCell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05137067 | Jan 2021 → Oct 2022 | breast cancer, lung cancer, prostate cancer | Optimal Health Research | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RaproCell | “Dietary Supplement (RaproCell)” NCT05137067 ↗ |